PAHC

Phibro Animal Health Corporation

PAHC, USA

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

https://www.pahc.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

Quarterly

Rate:

0.12

Next Payout:

Dec 17, 2025

Yield:

1.1955 %
PAHC
stock
PAHC

Phibro Animal Health Corporation $PAHC Stock Position Increased by Ranger Investment Management L.P. MarketBeat

Read more →
PAHC
stock
PAHC

G2 Investment Partners Management LLC Invests $1.41 Million in Phibro Animal Health Corporation $PAHC MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$43

Analyst Picks

Strong Buy

0

Buy

0

Hold

2

Sell

2

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

High

24.36

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

5.27

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

8.51 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.91 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-1.24 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

3.45

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 44.17% of the total shares of Phibro Animal Health Corporation

1.

BlackRock Inc

(8.6135%)

since

2025/06/30

2.

Vanguard Group Inc

(3.8197%)

since

2025/06/30

3.

iShares Core S&P Small-Cap ETF

(2.991%)

since

2025/08/31

4.

State Street Corp

(2.2434%)

since

2025/06/30

5.

ExodusPoint Capital Management, LP

(1.6786%)

since

2025/06/30

6.

Vanguard Total Stock Mkt Idx Inv

(1.5505%)

since

2025/07/31

7.

Renaissance Technologies Corp

(1.5069%)

since

2025/06/30

8.

Dimensional Fund Advisors, Inc.

(1.3748%)

since

2025/06/30

9.

Geode Capital Management, LLC

(1.3691%)

since

2025/06/30

10.

CastleKnight Management LP

(1.3109%)

since

2025/06/30

11.

iShares Russell 2000 ETF

(1.2182%)

since

2025/08/31

12.

Morgan Stanley - Brokerage Accounts

(1.2134%)

since

2025/06/30

13.

Nuveen, LLC

(1.1342%)

since

2025/06/30

14.

Dana Investment Advisors Inc

(0.9693%)

since

2025/06/30

15.

Brandes Investment Partners & Co

(0.9261%)

since

2025/06/30

16.

Ranger Investment Management LP

(0.8831%)

since

2025/06/30

17.

Millennium Management LLC

(0.7059%)

since

2025/06/30

18.

Arrowstreet Capital Limited Partnership

(0.6786%)

since

2025/06/30

19.

Bank of New York Mellon Corp

(0.6633%)

since

2025/06/30

20.

Amvescap Plc.

(0.649%)

since

2025/06/30

21.

Charles Schwab Investment Management Inc

(0.6413%)

since

2025/06/30

22.

Jacobs Levy Equity Management, Inc.

(0.6044%)

since

2025/06/30

23.

Crawford Investment Counsel, Inc

(0.5826%)

since

2025/06/30

24.

BlackRock Global Equity Mkt Netrl Instl

(0.5647%)

since

2025/07/31

25.

CREF Stock R3

(0.5431%)

since

2025/07/31

26.

Vanguard Institutional Extnd Mkt Idx Tr

(0.5361%)

since

2025/07/31

27.

Fidelity Small Cap Index

(0.5055%)

since

2025/06/30

28.

Nuveen Quant Small Cap Equity R6

(0.5039%)

since

2025/07/31

30.

iShares Russell 2000 Growth ETF

(0.4468%)

since

2025/08/31

31.

iShares S&P Small-Cap 600 Growth ETF

(0.4307%)

since

2025/08/31

32.

Crawford Small Cap Equity

(0.4226%)

since

2025/06/30

33.

Crawford Small Cap Dividend

(0.3954%)

since

2025/07/31

34.

Acadian Global Small-Cap Equity CIT Cl A

(0.3826%)

since

2025/03/04

35.

Vanguard Tax-Managed Small Cap Adm

(0.3267%)

since

2025/07/31

36.

Ranger Micro Cap

(0.3168%)

since

2025/06/30

37.

Fidelity Extended Market Index

(0.2733%)

since

2025/07/31

38.

SPDR® S&P 600 Small Cap Growth ETF

(0.2489%)

since

2025/08/31

39.

WisdomTree US SmallCap Dividend ETF

(0.2485%)

since

2025/08/29

40.

Schwab US Small-Cap ETFâ„¢

(0.2416%)

since

2025/08/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0.73

EPS Estimate

0.6033

EPS Difference

0.1267

Surprise Percent

21.0012%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(2.5)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Fair GARP(3.5)
Growth
Moderate Growth(3.5)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Moderate Quality(3.5)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.